Krüppel Like Factor 6 Splice Variant 1 (KLF6-SV1) Overexpression Recruits Macrophages to Participate in Lung Cancer Metastasis by Up-regulating TWIST1
Overview
Pharmacology
Affiliations
The aim of this study was to investigate the mechanism by which KLF6-SV1 promoted lung cancer metastasis through tumor-associated macrophages (TAMs). Plasmid transfection was used to construct cells that upregulated or silenced gene. Tumor-bearing mouse model was established using A549 cells. SP staining was performed to detect the CD163 and CD68. Six-well plates and Transwell chamber were used for co-culture of lung cancer A549 cells and macrophages. CCK-8 and Transwell assay were applied to detected the cell viability and migration respectively. Protein and mRNA were tested by Western blot and quantitative real-time polymerase chain reaction (qRT-PCR).KLF6-SV1 overexpression promoted the expression levels of TWIST1 and CCL2, and also induce macrophage polarization to M2 and epithelial-mesenchymal transition (EMT). In vitro experiments showed that KLF6-SV1 might regulate the migration of lung cancer cells by regulating the expression of TWIST1 and CCL-2. M2 macrophages did not affect the expression of KLF6-SV1, TWIST1 and CCL-2. The co-culture system could up-regulate the EMT of A549 cells.Overexpression of KLF6-SV1 promoted the expression of TWIST1 and CCL2, and up-regulation of TWIST1 expression might promote the infiltration of M2 macrophages, which promoted the involvement of EMT in the metastasis of lung cancer cells.
Cancer stem cells: advances in knowledge and implications for cancer therapy.
Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z Signal Transduct Target Ther. 2024; 9(1):170.
PMID: 38965243 PMC: 11224386. DOI: 10.1038/s41392-024-01851-y.
Abnormal expression of Krüppel-like transcription factors and their potential values in lung cancer.
Shi Y, Yao M, Shen S, Wang L, Yao D Heliyon. 2024; 10(7):e28292.
PMID: 38560274 PMC: 10979174. DOI: 10.1016/j.heliyon.2024.e28292.
Tumor-associated macrophages: an effective player of the tumor microenvironment.
Basak U, Sarkar T, Mukherjee S, Chakraborty S, Dutta A, Dutta S Front Immunol. 2023; 14:1295257.
PMID: 38035101 PMC: 10687432. DOI: 10.3389/fimmu.2023.1295257.
Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy.
Liu L, Chen G, Gong S, Huang R, Fan C Front Immunol. 2023; 14:1274547.
PMID: 38022518 PMC: 10679371. DOI: 10.3389/fimmu.2023.1274547.
Krüppel-like factors in tumors: Key regulators and therapeutic avenues.
Zhang Y, Yao C, Ju Z, Jiao D, Hu D, Qi L Front Oncol. 2023; 13:1080720.
PMID: 36761967 PMC: 9905823. DOI: 10.3389/fonc.2023.1080720.